Conference · Palm Beach, Florida
Orphan Drugs Market Access and Regulatory Affairs
Pharmaceuticals
Key numbers
- Editions on record
- 1first in 2014
About Orphan Drugs Market Access and Regulatory Affairs
Many blockbuster drugs will lose their exclusivity in the next five years. Therefore, the current economic situation has shifted the focus of many pharmaceutical companies from essential medicines to orphan drugs.
> Hear about the Latest Trends and Developments in Orphan Drugs Legislation
> Learn about Early Access to Orphan Drugs for Patients with Unmet Medical Need
> Discuss Orphan-Drug Designations and Marketing Approvals in the New Millennium and FDA and EMA Experiences
> Explore the Regulatory Landscape for Orphan Drug Development in order to Anticipate Future Changes
> Early access to Orphan Drugs for patients with unmet medical need
> Patient Centered Approach Seen by Patients
> Orphan Drug Designations and Marketing Approvals in the New Millennium
> Road from R&D to Market and more
SPEAKER PANEL
Dr. Carlos R. Camozzi,JuSpeaker Juan Fuertes,Mark Corbett,Cecil Nick, Diego Ardigo
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2014 | 24 Sep 2014 | Webinar Venue Online | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Orphan Drugs Market Access and Regulatory Affairs?
The next dates haven't been confirmed. The last edition we have on record was 24 Sep 2014.
Where is it held?
The last edition we have was at Webinar Venue, Palm Beach, Florida.